Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP

Science

Volumn 280, Issue 5371, 1998, Pages 1940-1943

  Blitzer, Robert D ^a   Connor, John H ^b   Brown, George P ^a   Wong, Tony ^a   Shenolikar, Shirish ^b   Iyengar, Ravi ^a   Landau, Emmanuel M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; PHOSPHATASE;

ANIMAL TISSUE; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; LONG TERM POTENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARRIER PROTEINS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ELECTRIC STIMULATION; ENZYME INHIBITORS; HIPPOCAMPUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LONG-TERM POTENTIATION; MALE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SYNAPSES; THIONUCLEOTIDES;

ANIMALIA;

EID: 0032546994     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.280.5371.1940     Document Type: Article

References (35)

1. T. V. Bliss and G. L. Collingridge, Nature 361, 31 (1993); R. C. Malenka and R. A. Nicoll, Trends Neurosci. 16, 521 (1993).
2. T. V. Bliss and G. L. Collingridge, Nature 361, 31 (1993); R. C. Malenka and R. A. Nicoll, Trends Neurosci. 16, 521 (1993).
3. D. L. Pettit, S. Perlman, R. Malinow, Science 266, 1881 (1994); P. M. Lledo et al., Proc. Natl. Acad. Sci. U.S.A. 92, 11175 (1995).
4. D. L. Pettit, S. Perlman, R. Malinow, Science 266, 1881 (1994); P. M. Lledo et al., Proc. Natl. Acad. Sci. U.S.A. 92, 11175 (1995).
5. J. Lisman, R. C. Malenka, R. A. Nicoll, R. Malinow, Science 276, 2001 (1997).
6. T. Abel et al., Cell 88, 615 (1997).
7. R. D. Blitzer, T. Wong, R. Nouranifar, R. Iyengar, E. M. Landau, Neuron 15, 1403 (1995).
8. R. Iyengar, Science 271, 461 (1996).
9. 35-thiophosphorylated I-1, T35A nonphosphorylatable I-1, autocamtide-3 and a related inactive control peptide (KKALHRQEAVDAL and KKALHAQERVDAL, respectively; gifts of A. P. Braun and H. Schulman) (28), and Rp-cAMPS were applied in the intracellular electrode and allowed to diffuse into the cell. In these experiments, HFS was delivered 40 to 60 min after impalement. For experiments in which Rp-cAMPS was applied in the superfusate, slices were exposed to 100 μM Rp-cAMPS in a maintenance chamber for 2 to 6 hours before recording. Synaptic stimulation consisted of monophasic, constant-current pulses of 100-μs duration delivered to the Schaffer collaterals (stratum radiatum in area CA3). A series of test pulses (four pulses at 0.2 Hz) was given every 5 or 10 min, and the excitatory postsynaptic potentials (EPSPs) within each series were averaged. EPSP amplitude and maximum initial slope (defined as the greatest slope within any 1-ms interval between the stimulus artifact and the EPSP peak) were measured offline for the averaged waveforms. LTP was induced by three trains of 100 pulses delivered at 100 Hz, separated by 10 min. The stimulus intensity used for HFS was adjusted to produce a 20-to 25-mV intracellular EPSP when measured from a membrane voltage of -80 mV; during HFS, the holding current was removed. Data were analyzed with either Student's t test or analyses of variance followed by Newman-Keuls post hoc comparisons. Summary data are presented as group means ± SEM.
10. T. S. Ingebritsen and P. Cohen, Science 221, 331 (1983).
11. H. Sakagami, K. Ebina, H. Kondo, Mol. Brain Res. 25, 7 (1994).
12. R. M. Mulkey, S. Endo, S. Shenolikar, R. C. Malenka, Nature 369, 486 (1994).
13. cDNAs encoding wild-type and nonphosphorylat-able (T35A) human I-1 were subcloned into the pT7-7 and pT7-5 vectors, respectively. The vectors were transformed into Escherichia coli BL21 (DE3). The recombinant proteins were expressed and purified by sequential trichloracetic acid (TCA) precipitation with I-1 purified from rabbit skeletal muscle as a marker. Homogeneously purified I-1 was obtained with preparative SDS-polyacrylamide gel electrophoresis (PAGE), and the purified proteins were phosphorylated with PKA and adenosine triphosphate (ATP)-γ-S [S. Endo, X. Zhou, J. Connor, B. Wang, S. Shenolikar, Biochemistry 35, 5220 (1996)].
14. Field potentials were monitored and HFS delivered as described (7); 2 to 3 min after, the final train slices were removed from the recording chamber and placed on a cold plate. The CA1 region was rapidly dissected out and frozen at -70°C. Individual CA1 samples were lysed in 100 μl of lysis buffer [50 mM tris, 4 mM EGTA, 10 mM EDTA, 15 mM Na phosphate, 100 mM β-glycerophosphate, 10 mM NaF, 0.1 mM pepstatin, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 2 mM benzamidine (pH 7.5)] and ground three times for 30 s with a pellet pestle (Kontes glassware, Vineland, NJ). The resulting lysate was spun down at 15,000g at 4°C for 10 min, and the supernatant was then assayed for total protein concentration. Twenty micrograms of protein from each sample was run on a 15% SDS-PAGE gel. The samples were transferred onto a polyvinylidene difluoride membrane overnight (25-mA constant current) and then blotted with an antibody to either phosphorylated DARPP-32/I-1 or recombinant human I-1. The monoclonal antibody (mAb) to phosphorylated DARPP-32/I-1 (provided by G. L. Snyder and P. Greengard) (29) was blotted at 1/1000 dilution into tris-buffered saline (TBS) + 0.3% Tween 20. It was probed with a horseradish peroxidase (HRP)-conjugated antibody to mouse, diluted 1/2500 in TBS + 0.3% Tween. The polyclonal antibody to human I-1 was blotted at 1/2500 dilution in TBS and probed with 1/2500 dilution of antibody to rabbit. Both blots were developed with enhanced chemiluminescence (ECL), revealing bands at 28 kD, which correspond to native I-1 in these gels.
15. Hippocampal slices were treated and dissected as described above (7, 12). Individual CA1 regions were homogenized in 50 mM tris (pH 7.5), 0.2 mM EDTA, 0.2 mM EGTA, leupeptin (2 μg/ml), aprotinin (2 μg/ml), and 10 nM okadaic acid. Phosphatase activity of 20 ng of protein of CA1 homogenate was measured with the Protein Phosphatase Assay System (GIBCO BRL) in a final concentration of 3.3 nM okadaic acid. With this method, inclusion of 100 nM thiophosphorylated I-1 inhibited >90% of phosphatase activity, confirming the selectivity of the system for PP1.
16. M. B. Kennedy, Trends Neurosci. 20, 264 (1997).
17. K. Fukunaga, D. Muller, E. Miyamoto, J. Biol. Chem. 270, 6119 (1995); A. P. Braun and H. Schulman, Annu. Rev. Physiol. 57, 417 (1995).
18. K. Fukunaga, D. Muller, E. Miyamoto, J. Biol. Chem. 270, 6119 (1995); A. P. Braun and H. Schulman, Annu. Rev. Physiol. 57, 417 (1995).
19. A. Barria, D. Muller, V. Derkach, L. C. Griffith, T. R. Soderling, Science 276, 2042 (1997).
20. S. M. Shields, T. S. Ingebritsen, P. T. Kelly, J. Neurosci. 5, 3414 (1985); S. Strack, M. A. Barban, B. E. Wadzinski, R. J. Colbran, J. Neurochem. 68, 2119 (1997).
21. S. M. Shields, T. S. Ingebritsen, P. T. Kelly, J. Neurosci. 5, 3414 (1985); S. Strack, M. A. Barban, B. E. Wadzinski, R. J. Colbran, J. Neurochem. 68, 2119 (1997).
22. K. P. Giese, N. B. Federov, R. K. Filipkowski, A. J. Silva, Science 279, 870 (1998).
23. 286-phosphorylated CaMKII α subunit (Affinity Bioreagents, Golden, CO) [B. L. Patton, S. S. Molloy, M. B. Kennedy, Mol. Biol. Cell 4, 159 (1993)] or a polyclonal antibody to CaMKII (Upstate Biotechnology, Lake Placid, NY). The mAb to autophosphorylated CaMKII was blotted at 1/2000 dilution into 5% nonfat dried milk, 0.1% Tween, and 1 μM microcystin-LR in phosphate-buffered saline (PBS). It was probed with an HRP-conjugated antibody to mouse at 1/3000 dilution into 5% nonfat dried milk and 0.1% Tween in PBS. The polyclonal antibody to CaMKII was blotted at 1 μg/ml in 3% nonfat dried milk in PBS and probed with a 1/3000 dilution of antibody to rabbit. Both blots were developed with ECL, revealing a band at ∼50 kD (corresponding to the α subunit of CaMKII).
24. 32P incorporated into substrate peptide was determined by liquid scintillation counting.
25. A. P. Braun and H. Schulman, J. Physiol. 488, 37 (1995).
26. G. W. Sharp, Annu. Rev. Med. 24, 19 (1973); S. Traverse, N. Gomez, H. Paterson, C. Marshall, P. Cohen, Biochem. J. 288, 351 (1992).
27. G. W. Sharp, Annu. Rev. Med. 24, 19 (1973); S. Traverse, N. Gomez, H. Paterson, C. Marshall, P. Cohen, Biochem. J. 288, 351 (1992).
28. Y.-Y. Huang and E. R. Kandel, Learning Mem. 1, 74 (1994).
29. D. G Winder, I. M. Mansuy, M. Osman, T. M. Moallem, E. R. Kandel, Cell 92, 25 (1998).
30. J. Lisman, Trends Neurosci. 17, 406 (1994).
31. J. L. Yakel, Trends Pharmacol. Sci. 18, 124 (1997).
32. L. Cahill, B. Prins, M. Weber, J. L. McGaugh, Nature 371, 702 (1994).
33. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; D, Asp; E, Glu; H, His; K, Lys; L, Leu; Q, Gln; R, Arg; and V, Val.
34. G. L. Snyder et al., J. Neurosci. 12, 3071 (1992).
35. Funded by grants from NIH (NS33646 to E.M.L., GM54508 to R.I., and DK52054 to S.S.) and the Veterans Administration (to E.M.L.). G.P.B. is supported by an individual postdoctoral National Research Service Award (GM18887). We thank H. Schulman and A. P. Braun for initial samples of autocamtide-3 and control peptide and for valuable discussions regarding phosphorylated-CaMKII antibodies.